Skip to content
1005-Activated T Cell Vesicles Boost Antigen Presentation episode artwork

May 20, 2026 27 min

1005-Activated T Cell Vesicles Boost Antigen Presentation

from Paper Talk

This research identifies a novel communication pathway where activated T cell-derived extracellular vesicles (ATEVs) enhance the body’s ability to recognize and destroy tumors. These vesicles carry double-stranded genomic DNA enriched with immune-related genes, which they deliver directly into the nuclei of dendritic and cancer cells. This transfer is facilitated by granzyme B, a protein within the vesicles that temporarily disrupts the recipient cell's nuclear envelope to allow for transient gene expression. By restoring and boosting antigen processing and presentation, ATEVs significantly increase the visibility of "cold" or immune-silent tumors to the immune system. When utilized as an acellular immunotherapy, these vesicles overcome tumor evasion and work synergistically with checkpoint inhibitors to halt cancer progression. Ultimately, the study highlights a natural, non-viral method of horizontal gene transfer that strengthens anti-tumor immunity without the risks of permanent genetic integration. References: Hu M, Liu D A, Wortzel I, et al. Activated T cell extracellular vesicle DNA transfer enhances antigen presentation and anti-tumor immunity[J]. Cancer Cell, 2026. 前往小宇宙评论区与主播互动

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

1005-Activated T Cell Vesicles Boost Antigen Presentation

0:00 27:28

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Paper Talk?

This episode is 27 minutes long.

When was this Paper Talk episode published?

This episode was published on May 20, 2026.

Can I download this Paper Talk episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.